{
  "id": "enwiki-001357686227",
  "slug": "ebselen",
  "title": "Ebselen",
  "qid": "",
  "lead": "Ebselen (also called PZ 51, DR3305, and SPI-1005), is a synthetic organoselenium molecule under preliminary investigation as a drug candidate. It belongs to the class of compounds related to benzene and its derivatives. It is being developed by the Seattle biotechnology company, Sound Pharmaceuticals, Inc. It has also been reported to target tubulin, blocking its polymerization. Ebselen has been entered into clinical trials as a lead compound intended for the potential treatment of various diseases. Its most advanced clinical trial is a Phase III study in people with Meniere's disease, completed in July 2024. In vitro, ebselen is a mimic of glutathione peroxidase and reacts with peroxynitrite. It is purported to have antioxidant and anti-inflammatory properties.",
  "body": "Ebselen (also called PZ 51, DR3305, and SPI-1005), is a synthetic organoselenium molecule under preliminary investigation as a drug candidate. It belongs to the class of compounds related to benzene and its derivatives. It is being developed by the Seattle biotechnology company, Sound Pharmaceuticals, Inc. It has also been reported to target tubulin, blocking its polymerization. Ebselen has been entered into clinical trials as a lead compound intended for the potential treatment of various diseases. Its most advanced clinical trial is a Phase III study in people with Meniere's disease, completed in July 2024. In vitro, ebselen is a mimic of glutathione peroxidase and reacts with peroxynitrite. It is purported to have antioxidant and anti-inflammatory properties. ==Research== Ebselen is in preliminary clinical development for the potential treatment of hearing loss and depression, among other medical indications. ==See also== List of investigational antidepressants List of investigational bipolar disorder drugs ==External links== Sound Pharmaceuticals, Inc., corporate website",
  "categories": [
    "106462794",
    "109455715",
    "23603337",
    "23815562",
    "26220375",
    "35379581",
    "43371249",
    "43371251",
    "46695057",
    "50769796",
    "56146128",
    "67819206",
    "75489665"
  ],
  "license": "CC BY-SA 4.0",
  "source_uri": "https://en.wikipedia.org/w/index.php?oldid=1357686227",
  "content_hash": "",
  "created_at": null,
  "updated_at": 1780531167.0,
  "claims": [],
  "contradictions": [],
  "confidence": 0.6,
  "csl": {
    "id": "enwiki-001357686227",
    "type": "webpage",
    "title": "Ebselen",
    "author": [
      {
        "family": "Anticloud FZ LLE",
        "literal": "Anticloud FZ LLE"
      }
    ],
    "container-title": "encyclopegia.org",
    "publisher": "Anticloud FZ LLE",
    "publisher-place": "Dubai, United Arab Emirates",
    "URL": "https://encyclopegia.org/a/ebselen",
    "issued": {
      "date-parts": [
        [
          2026,
          11,
          18
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          2026,
          11,
          18
        ]
      ]
    },
    "license": "CC BY-SA 4.0",
    "DOI": "eo1:enwiki-001357686227",
    "isBasedOn": "https://en.wikipedia.org/w/index.php?oldid=1357686227",
    "note": "Immutable snapshot enwiki-001357686227"
  }
}